A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 957,950 shares of EW stock, worth $71 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
957,950
Previous 1,154,757 17.04%
Holding current value
$71 Million
Previous $107 Million 40.73%
% of portfolio
0.09%
Previous 0.15%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$59.7 - $93.78 $11.7 Million - $18.5 Million
-196,807 Reduced 17.04%
957,950 $63.2 Million
Q2 2024

Jul 19, 2024

BUY
$84.3 - $94.31 $857,836 - $959,698
10,176 Added 0.89%
1,154,757 $107 Million
Q1 2024

Apr 22, 2024

BUY
$72.54 - $95.56 $3.35 Million - $4.42 Million
46,217 Added 4.21%
1,144,581 $109 Million
Q4 2023

Jan 16, 2024

SELL
$61.71 - $77.76 $2.33 Million - $2.94 Million
-37,790 Reduced 3.33%
1,098,364 $83.8 Million
Q3 2023

Oct 24, 2023

BUY
$69.28 - $93.38 $4.32 Million - $5.83 Million
62,382 Added 5.81%
1,136,154 $78.7 Million
Q2 2023

Jul 25, 2023

SELL
$81.41 - $94.33 $346,318 - $401,279
-4,254 Reduced 0.39%
1,073,772 $101 Million
Q1 2023

Apr 14, 2023

BUY
$74.26 - $84.51 $5.71 Million - $6.5 Million
76,880 Added 7.68%
1,078,026 $89.2 Million
Q4 2022

Feb 08, 2023

SELL
$68.3 - $87.44 $1.93 Million - $2.47 Million
-28,265 Reduced 2.75%
1,001,146 $74.7 Million
Q3 2022

Oct 25, 2022

BUY
$82.37 - $107.29 $1.87 Million - $2.44 Million
22,755 Added 2.26%
1,029,411 $85.1 Million
Q2 2022

Aug 12, 2022

BUY
$86.5 - $128.27 $339,772 - $503,844
3,928 Added 0.39%
1,006,656 $95.7 Million
Q1 2022

May 11, 2022

BUY
$101.96 - $128.34 $4.53 Million - $5.7 Million
44,407 Added 4.63%
1,002,728 $118 Million
Q4 2021

Feb 08, 2022

BUY
$106.37 - $130.68 $755,758 - $928,481
7,105 Added 0.75%
958,321 $124 Million
Q3 2021

Nov 02, 2021

BUY
$102.91 - $122.75 $4.85 Million - $5.78 Million
47,101 Added 5.21%
951,216 $108 Million
Q2 2021

Aug 11, 2021

BUY
$83.84 - $104.76 $12.5 Million - $15.7 Million
149,431 Added 19.8%
904,115 $93.6 Million
Q1 2021

May 14, 2021

BUY
$78.68 - $90.67 $4.91 Million - $5.66 Million
62,448 Added 9.02%
754,684 $63.1 Million
Q4 2020

Feb 12, 2021

BUY
$71.69 - $91.23 $8.53 Million - $10.9 Million
118,982 Added 20.76%
692,236 $63.2 Million
Q3 2020

Nov 04, 2020

BUY
$67.19 - $87.44 $25.6 Million - $33.3 Million
380,267 Added 197.04%
573,254 $45.8 Million
Q2 2020

Jul 17, 2020

BUY
$57.54 - $76.95 $7.45 Million - $9.96 Million
129,482 Added 203.89%
192,987 $13.3 Million
Q1 2020

Apr 21, 2020

SELL
$52.41 - $81.0 $1 Million - $1.55 Million
-19,093 Reduced 23.12%
63,505 $12 Million
Q4 2019

Feb 12, 2020

BUY
$71.7 - $82.09 $1.35 Million - $1.54 Million
18,806 Added 29.48%
82,598 $19.3 Million
Q3 2019

Nov 07, 2019

BUY
$61.55 - $75.43 $226,319 - $277,356
3,677 Added 6.12%
63,792 $14 Million
Q2 2019

Aug 06, 2019

BUY
$55.74 - $64.41 $1.02 Million - $1.18 Million
18,381 Added 44.04%
60,115 $11.1 Million
Q1 2019

May 06, 2019

BUY
$47.89 - $64.05 $320,527 - $428,686
6,693 Added 19.1%
41,734 $7.99 Million
Q4 2018

Feb 11, 2019

BUY
$46.41 - $56.94 $130,504 - $160,115
2,812 Added 8.73%
35,041 $5.37 Million
Q3 2018

Nov 14, 2018

BUY
$45.7 - $58.03 $904,265 - $1.15 Million
19,787 Added 159.03%
32,229 $5.61 Million
Q2 2018

Jul 30, 2018

BUY
$42.45 - $51.3 $141,231 - $170,675
3,327 Added 36.5%
12,442 $1.81 Million
Q1 2018

Apr 16, 2018

BUY
$37.19 - $47.45 $2,045 - $2,609
55 Added 0.61%
9,115 $1.27 Million
Q4 2017

Feb 09, 2018

SELL
$33.79 - $39.39 $23,179 - $27,021
-686 Reduced 7.04%
9,060 $1.02 Million
Q3 2017

Oct 26, 2017

SELL
$36.29 - $38.83 $81,471 - $87,173
-2,245 Reduced 18.72%
9,746 $1.07 Million
Q2 2017

Aug 15, 2017

BUY
N/A
11,991
11,991 $1.42 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.